Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Stefania De Propris

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Leukemia Research|January 13, 2016
CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalitiesSabina Chiaretti, Fulvia Brugnoletti, Monica Messina, et al.
Hematological Oncology|July 13, 2016
Independent prognostic impact of CD15 on complete remission achievement in patients with acute myeloid leukemiaMarta Chisini, Caterina Stefanizzi, Teresa Ceglie, et al.
The New England Journal of Medicine|October 21, 2020
Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in AdultsRobin Foà, Renato Bassan, Antonella Vitale, et al.
American Journal of Hematology|December 7, 2020
Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trialAnna Maria Testi, Martina Canichella, Antonella Vitale, et al.
Haematologica|May 7, 2016
RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implicationsValentina Gianfelici, Sabina Chiaretti, Sofie Demeyer, et al.
Blood|September 21, 2011
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaRobin Foà, Antonella Vitale, Marco Vignetti, et al.
Cancers|April 13, 2023
Consensus for Flow Cytometry Clinical Report on Multiple Myeloma: A Multicenter Harmonization Process Merging Laboratory Experience and Clinical NeedsIole Cordone, Rachele Amodeo, Silvia Bellesi, et al.
Blood Advances|June 5, 2023
Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trialRenato Bassan, Sabina Chiaretti, Irene Della Starza, et al.
Blood|February 26, 2025
Up-front blinatumomab improves MRD clearance and outcome in adult Ph- B-lineage ALL: the GIMEMA LAL2317 phase 2 studyRenato Bassan, Sabina Chiaretti, Irene Della Starza, et al.
American Journal of Hematology|January 14, 2014
Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patientsRobin Foà, Ilaria Del Giudice, Antonio Cuneo, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Leukemia Research|January 13, 2016
CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalitiesSabina Chiaretti, Fulvia Brugnoletti, Monica Messina, et al.
Hematological Oncology|July 13, 2016
Independent prognostic impact of CD15 on complete remission achievement in patients with acute myeloid leukemiaMarta Chisini, Caterina Stefanizzi, Teresa Ceglie, et al.
The New England Journal of Medicine|October 21, 2020
Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in AdultsRobin Foà, Renato Bassan, Antonella Vitale, et al.
American Journal of Hematology|December 7, 2020
Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trialAnna Maria Testi, Martina Canichella, Antonella Vitale, et al.
Haematologica|May 7, 2016
RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implicationsValentina Gianfelici, Sabina Chiaretti, Sofie Demeyer, et al.
Blood|September 21, 2011
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaRobin Foà, Antonella Vitale, Marco Vignetti, et al.
Cancers|April 13, 2023
Consensus for Flow Cytometry Clinical Report on Multiple Myeloma: A Multicenter Harmonization Process Merging Laboratory Experience and Clinical NeedsIole Cordone, Rachele Amodeo, Silvia Bellesi, et al.
Blood Advances|June 5, 2023
Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trialRenato Bassan, Sabina Chiaretti, Irene Della Starza, et al.
Blood|February 26, 2025
Up-front blinatumomab improves MRD clearance and outcome in adult Ph- B-lineage ALL: the GIMEMA LAL2317 phase 2 studyRenato Bassan, Sabina Chiaretti, Irene Della Starza, et al.
American Journal of Hematology|January 14, 2014
Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patientsRobin Foà, Ilaria Del Giudice, Antonio Cuneo, et al.
Pageof 7